Activation of mitogen activated protein kinase in dolichyl phosphate-induced apoptosis in U937 cells

Area of Science:

• Cell Biology
• Molecular Biology
• Biochemistry

Background:

• Dolichyl phosphate (Dol-P) is a key component in glycoprotein synthesis.
• The role of Dol-P in inducing programmed cell death (apoptosis) is not fully understood.
• Leukemia cell lines provide a model for studying apoptosis induction.

Purpose of the Study:

• To investigate the mechanism by which exogenous dolichyl phosphate (Dol-P) induces apoptosis in U937 leukemia cells.
• To determine the involvement of mitogen-activated protein kinase (MAP kinase) signaling in Dol-P-induced apoptosis.

Main Methods:

• Treatment of U937 cells with exogenous dolichyl phosphate (Dol-P).
• Assessment of apoptosis using DNA fragmentation assays.
• Monitoring of p42 mitogen-activated protein kinase (MAP kinase) phosphorylation and activation.
• Inhibition studies using herbimycin A to block tyrosine phosphorylation of MAP kinase.

Main Results:

• Exogenous dolichyl phosphate (Dol-P) induced apoptosis in U937 cells within 4 hours.
• MAP kinase activation, indicated by p42 MAP kinase phosphorylation, preceded DNA fragmentation.
• MAP kinase activation peaked at 30 minutes post-Dol-P treatment.
• Inhibition of MAP kinase tyrosine phosphorylation by herbimycin A significantly reduced DNA fragmentation and partially inhibited cell death.

Conclusions:

• Dolichyl phosphate (Dol-P)-induced apoptosis in U937 leukemia cells is mediated by the MAP kinase signaling cascade.
• MAP kinase activation is a critical early event in the apoptotic pathway triggered by Dol-P.
• Targeting the MAP kinase pathway may offer therapeutic strategies for leukemia.